The advertisement promotes NUBEQA® (darolutamide), highlighting its relevance for individuals experiencing rising PSA levels while undergoing ADT (androgen deprivation therapy).
Creative Information
| CID: | ff496ff9-c40d-4cc6-8382-9e25874d2443 |
| CRID: | 82_1075-869375 |
| Domain: | nubeqa-us.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $0.95 |
| Timestamp: | 11/18/2025, 8:30:49 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/18/2025, 9:07:49 PM | 8.78s | |
| adomain_analysis | success | 11/18/2025, 10:34:46 PM | 3.15s | |
| adomain_capture | success | 11/18/2025, 10:34:42 PM | 0.08s | |
| ad_render | success | 11/18/2025, 9:07:40 PM | 25.22s | |
| brand_mapping | success | 11/18/2025, 10:34:43 PM | 1.02s | |
Analysis Results
Ad Format: banner
Brands: Nubeqa
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1172.03 KB | ||||||||||||||||||||||
| Render Time: | 9.72 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1172.07 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


